ArticleScientific reports2025

Distinct safety profiles of albumin-bound nab-paclitaxel and paclitaxel in pancreatic cancer focusing on hematologic and hepatobiliary risks.

Nan Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.